Stay updated on Pembrolizumab in mHSPC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in mHSPC Clinical Trial page.

Latest updates to the Pembrolizumab in mHSPC Clinical Trial page
- CheckyesterdayChange DetectedThe revision label in the record history updates from v3.5.3 to v3.5.4, signaling a new version of the page’s history. The substantive content of the record remains unchanged.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page’s displayed software/UI revision number was updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check30 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision history updated with the addition of v3.5.0 and removal of v3.4.3.SummaryDifference0.1%

- Check66 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.1%

- Check73 days agoChange DetectedNew version entries appear in the Record History, reflecting updates such as recruitment status and IPD sharing metadata. No substantive study data or results are changed in these updates.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in mHSPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in mHSPC Clinical Trial page.